SHMT1 siRNA-Loaded hyperosmotic nanochains for blood-brain/tumor barrier post-transmigration therapy
- Authors
- Pandey, Shambhavi; Lee, Myung Chul; Lim, Jae woon; Choung, Yun-Hoon; Jang, Kyoung-Je; Park, Sang Bae; Kim, Jae Eun; Chung, Jong Hoon; Garg, Pankaj
- Issue Date
- Feb-2022
- Publisher
- Pergamon Press Ltd.
- Keywords
- Nanochain; Hyperosmotic; BBB; BTB; Transmigration; NFAT5; Aspect ratio; SHMT1
- Citation
- Biomaterials, v.281
- Indexed
- SCIE
SCOPUS
- Journal Title
- Biomaterials
- Volume
- 281
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/1683
- DOI
- 10.1016/j.biomaterials.2021.121359
- ISSN
- 0142-9612
1878-5905
- Abstract
- The near-perivascular accumulation in solid tumors and short-lived span in circulation, derails even the most competent nanoparticles (NPs) from achieving their maximum therapeutic potential. Moreover, delivering them across the blood brain/tumor barrier (BBB/BTB) is further challenging to sought anticancer effect. To address these key challenges, we designed a linearly aligned nucleic acid-complexed polydixylitol-based polymeric nanochains (X-NCs), with inherent hyperosmotic properties enabling transmigration of the BBB/BTB and navigation through deeper regions of the brain tumor. The high aspect ratio adds shape-dependent functional aspects to parent particles by providing effective payload increment and nuclear factor of activated T cells-5 (NFAT5)mediated cellular uptake. Therefore, serine hydroxymethyltransferase 1 (SHMT1) siRNA-loaded nanochains not only demonstrated to transmigrate the BTB, but also resulted in remarkably reducing the tumor size to 97% in the glioblastoma xenograft brain tumor mouse models. Our study illustrates how the hyperosmotic nanochains with high aspect ratio and aligned structure can accelerate a therapeutic effect in aggressive brain tumors post transmigration of the BBB/BTB by utilizing an NFAT5 mode of uptake mechanism.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 농업생명과학대학 > 생물산업기계공학과 > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.